Home » Newsletters » BioWorld Science

BioWorld Science

April 12, 2007

View Archived Issues

Recent patents disclose novel analgesic agents

New treatment strategy for microbial infections claimed in recent Novozymes patent

Recent Asahi Kasei patent reports novel agents for treating glaucoma

MediGene and JDRF collaborate on mTCR therapeutics for type 1 diabetes

Novel glucocorticoid receptor agonist shows in vivo efficacy and improved safety profile

DELTA MI trial shows beneficial effects of KAI-9803 in myocardial infarction

Synergy seen with verotoxin-1 and monophosphoryl lipid A in mouse fibrosarcoma

Garenoxacin effective for Streptococcus pneumoniae respiratory tract infections

New data on hepatitis C treatments including pegylated interferon reported

Viral kinetics, mechanism of action of DEBIO-025 explored

[N-MeIle4]-cyclosporin and NM-107 exert synergistic anti-HCV activity in vitro

Pilot bioavailability study for immediate release CDT-fenofibrate tablets

FDA extends review period for Torisel NDA

Inhibitex to acquire FermaVir

MAESTRO-01 trial of MBP-8298 cleared to continue

ACR-16 studied in new phase Ib trial for schizophrenia

Enrollment completed in phase III trials of PF-3512676 for NSCLC

Renovis and Pfizer extend VR1 research collaboration

Dosing begins in phase I study of AC-220 for AML

Roche and Transgene establish HPV collaboration

Reolysin studied in phase II trial for metastatic sarcomas

Pancreatic cancer study of Erbitux plus gemcitabine misses endpoint

Swiss approval for phase III trial of CUV-1647 for erythropoietic protoporphyria

ARRY-797 to be studied in cancer patients

Protemix raises funds to advance pipeline

Imbalance in cardiovascular and neoplasm SAEs in alvimopan trial

PS-433540 well tolerated and potentially suited for once-daily administration

Follistim introduced in Japan for induction of ovulation in infertile women

Brovana available in U.S.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...